{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:00:18Z","timestamp":1778914818704,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T00:00:00Z","timestamp":1500854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK048520"],"award-info":[{"award-number":["P30-DK048520"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA164166"],"award-info":[{"award-number":["CA164166"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA169430"],"award-info":[{"award-number":["CA169430"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA046934"],"award-info":[{"award-number":["P30-CA046934"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","award":["KG081323"],"award-info":[{"award-number":["KG081323"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12672-017-0302-9","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T14:15:14Z","timestamp":1500905714000},"page":"269-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer"],"prefix":"10.1007","volume":"8","author":[{"given":"Elizabeth A","family":"Wellberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Allyson","family":"Checkley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin D","family":"Giles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stevi J","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robera","family":"Oljira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Wahdan-Alaswad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca M","family":"Foright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Edgerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger C","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer K","family":"Richer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kabos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann D","family":"Thor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepper","family":"Schedin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,24]]},"reference":[{"issue":"21","key":"302_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1001\/jama.2016.6458","volume":"315","author":"KM Flegal","year":"2016","unstructured":"Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315(21):2284\u20132291","journal-title":"JAMA"},{"issue":"10","key":"302_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DS Chan","year":"2014","unstructured":"Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Navarro Rosenblatt D, Thune I, Vieira R, Norat T (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO 25(10):1901\u20131914","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology \/ ESMO"},{"key":"302_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/epirev\/mxt010","volume":"36","author":"MF Munsell","year":"2014","unstructured":"Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A (2014) Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev 36:114\u2013136","journal-title":"Epidemiol Rev"},{"key":"302_CR4","doi-asserted-by":"crossref","unstructured":"Matthews SB, Thompson HJ (2016) The obesity-breast cancer conundrum: an analysis of the issues. Int J Mol Sci 17(6)","DOI":"10.3390\/ijms17060989"},{"issue":"5","key":"302_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamaoncol.2015.1546","volume":"1","author":"ML Neuhouser","year":"2015","unstructured":"Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, Ochs-Balcom HM, Thomson CA, Caan BJ, Tinker LF, Urrutia RP, Knudtson J, Anderson GL (2015) Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women\u2019s Health Initiative randomized clinical trials. JAMA Oncol 1(5):611\u2013621","journal-title":"JAMA Oncol"},{"key":"302_CR6","doi-asserted-by":"crossref","unstructured":"Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH (2013) Obesity, Diabetes, and Survival Outcomes in a Large Cohort of Early-Stage Breast Cancer Patients. Annals of oncology: official journal of the European Society for Medical Oncology\/ESMO","DOI":"10.1093\/annonc\/mdt224"},{"issue":"2","key":"302_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-014-3091-7","volume":"147","author":"SJ Ioannides","year":"2014","unstructured":"Ioannides SJ, Barlow PL, Elwood JM, Porter D (2014) Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review. Breast Cancer Res Treat 147(2):237\u2013248","journal-title":"Breast Cancer Res Treat"},{"key":"302_CR8","unstructured":"ACS (2015-2016) Breast Cancer Facts & Figures"},{"issue":"1","key":"302_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-009-0436-8","volume":"121","author":"F De Amicis","year":"2010","unstructured":"De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, Chamness GC, Hilsenbeck SG, Ando S, Fuqua SA (2010) Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. Breast Cancer Res Treat 121(1):1\u201311","journal-title":"Breast Cancer Res Treat"},{"key":"302_CR10","doi-asserted-by":"crossref","unstructured":"Fujii R, Hanamura T, Suzuki T, Gohno T, Shibahara Y, Niwa T, Yamaguchi Y, Ohnuki K, Kakugawa Y, Hirakawa H, Ishida T, Sasano H, Ohuchi N, Hayashi SI (2014) Increased Androgen Receptor Activity and Cell Proliferation in Aromatase Inhibitor-Resistant Breast Carcinoma. J Steroid Biochem Mol Biol","DOI":"10.1016\/j.jsbmb.2014.08.019"},{"key":"302_CR11","doi-asserted-by":"crossref","unstructured":"Rechoum Y, Rovito D, Iacopetta D, Barone I, Ando S, Weigel NL, O'Malley BW, Brown PH, Fuqua SA (2014) Ar Collaborates with Eralpha in Aromatase Inhibitor-Resistant Breast Cancer. Breast Cancer Res Treat","DOI":"10.1007\/s10549-014-3082-8"},{"issue":"7","key":"302_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/modpathol.2011.54","volume":"24","author":"LC Collins","year":"2011","unstructured":"Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM (2011) Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses\u2019 Health Study. Mod Pathol 24(7):924\u2013931","journal-title":"Mod Pathol"},{"issue":"5","key":"302_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10147-008-0770-6","volume":"13","author":"Y Ogawa","year":"2008","unstructured":"Ogawa Y, Hai E, Matsumoto K, Ikeda K, Tokunaga S, Nagahara H, Sakurai K, Inoue T, Nishiguchi Y (2008) Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 13(5):431\u2013435","journal-title":"Int J Clin Oncol"},{"issue":"15","key":"302_CR14","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1158\/0008-5472.CAN-09-0452","volume":"69","author":"AA Peters","year":"2009","unstructured":"Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL, Henshall SM, Birrell SN, Coetzee GA, Sutherland RL, Butler LM, Tilley WD (2009) Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Res 69(15):6131\u20136140","journal-title":"Cancer Res"},{"issue":"1","key":"302_CR15","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/bcr3599","volume":"16","author":"DR Cochrane","year":"2014","unstructured":"Cochrane DR, Bernales S, Jacobsen BM, Cittelly DM, Howe EN, D'Amato NC, Spoelstra NS, Edgerton SM, Jean A, Guerrero J, Gomez F, Medicherla S, Alfaro IE, McCullagh E, Jedlicka P, Torkko KC, Thor AD, Elias AD, Protter AA, Richer JK (2014) Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res 16(1):R7","journal-title":"Breast Cancer Res"},{"key":"302_CR16","doi-asserted-by":"crossref","unstructured":"D'Amato NC, Gordon MA, Babbs B, Spoelstra NS, Carson Butterfield KT, Torkko KC, Phan VT, Barton VN, Rogers TJ, Sartorius CA, Elias A, Gertz J, Jacobsen BM, Richer JK (2016) Cooperative Dynamics of Ar and Er Activity in Breast Cancer. Mol Cancer Res","DOI":"10.1158\/1541-7786.MCR-16-0167"},{"issue":"5\u20136","key":"302_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s12672-015-0232-3","volume":"6","author":"VN Barton","year":"2015","unstructured":"Barton VN, D'Amato NC, Gordon MA, Christenson JL, Elias A, Richer JK (2015) Androgen receptor biology in triple negative breast cancer: a case for classification as Ar+ or quadruple negative disease. Horm Cancer 6(5\u20136):206\u2013213","journal-title":"Horm Cancer"},{"issue":"6","key":"302_CR18","doi-asserted-by":"publisher","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovic B, Chen X, Estrada MV, Johnson KN, Shyr Y, Moses HL, Sanders ME, Pietenpol JA (2016) Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS One 11(6):e0157368","journal-title":"PLoS One"},{"issue":"3","key":"302_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1158\/1535-7163.MCT-14-0926","volume":"14","author":"VN Barton","year":"2015","unstructured":"Barton VN, D'Amato NC, Gordon MA, Lind HT, Spoelstra NS, Babbs BL, Heinz RE, Elias A, Jedlicka P, Jacobsen BM, Richer JK (2015) Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo. Mol Cancer Ther 14(3):769\u2013778","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"302_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1530\/ERC-16-0068","volume":"23","author":"F Caiazza","year":"2016","unstructured":"Caiazza F, Murray A, Madden SF, Synnott NC, Ryan EJ, O'Donovan N, Crown J, Duffy MJ (2016) Preclinical evaluation of the Ar inhibitor enzalutamide in triple-negative breast cancer cells. Endocr Relat Cancer 23(4):323\u2013334","journal-title":"Endocr Relat Cancer"},{"key":"302_CR21","doi-asserted-by":"crossref","unstructured":"Barton VN, Christenson JL, Gordon MA, Greene LI, Rogers TJ, Butterfield K, Babbs B, Spoelstra NS, D'Amato NC, Elias A, Richer JK (2017) Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-Like Population in Triple-Negative Breast Cancer. Cancer Res","DOI":"10.1158\/0008-5472.CAN-16-3240"},{"key":"302_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fnut.2016.00050","volume":"3","author":"ED Giles","year":"2016","unstructured":"Giles ED, Jackman MR, MacLean PS (2016) Modeling diet-induced obesity with obesity-prone rats: implications for studies in females. Front Nutr 3:50","journal-title":"Front Nutr"},{"key":"302_CR23","doi-asserted-by":"crossref","unstructured":"Maclean PS, Giles ED, Johnson GC, McDaniel SM, Fleming-Elder BK, Gilman KA, Andrianakos AG, Jackman MR, Shroyer KR, Schedin PJ (2009) A Surprising Link between the Energetics of Ovariectomy-Induced Weight Gain and Mammary Tumor Progression in Obese Rats. Obesity (Silver Spring)","DOI":"10.1038\/oby.2009.307"},{"issue":"24","key":"302_CR24","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1158\/0008-5472.CAN-12-1653","volume":"72","author":"ED Giles","year":"2012","unstructured":"Giles ED, Wellberg EA, Astling DP, Anderson SM, Thor AD, Jindal S, Tan AC, Schedin PS, Maclean PS (2012) Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res 72(24):6490\u20136501","journal-title":"Cancer Res"},{"issue":"4","key":"302_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/oby.2009.307","volume":"18","author":"PS MacLean","year":"2010","unstructured":"MacLean PS, Giles ED, Johnson GC, McDaniel SM, Fleming-Elder BK, Gilman KA, Andrianakos AG, Jackman MR, Shroyer KR, Schedin PJ (2010) A surprising link between the energetics of ovariectomy-induced weight gain and mammary tumor progression in obese rats. Obesity (Silver Spring) 18(4):696\u2013703","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"302_CR26","doi-asserted-by":"publisher","first-page":"R288","DOI":"10.1152\/ajpregu.00010.2004","volume":"287","author":"PS MacLean","year":"2004","unstructured":"MacLean PS, Higgins JA, Johnson GC, Fleming-Elder BK, Peters JC, Hill JO (2004) Metabolic adjustments with the development, treatment, and recurrence of obesity in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 287(2):R288\u2013R297","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"302_CR27","doi-asserted-by":"publisher","first-page":"R1634","DOI":"10.1152\/ajpregu.00219.2010","volume":"299","author":"ED Giles","year":"2010","unstructured":"Giles ED, Jackman MR, Johnson GC, Schedin PJ, Houser JL, MacLean PS (2010) Effect of the estrous cycle and surgical ovariectomy on energy balance, fuel utilization, and physical activity in lean and obese female rats. Am J Physiol Regul Integr Comp Physiol 299(6):R1634\u2013R1642","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"302_CR28","doi-asserted-by":"crossref","unstructured":"Checkley LA, Rudolph MC, Wellberg EA, Giles ED, Wahdan-Alaswad RS, Houck JA, Edgerton S, Thor AD, Schedin P, Anderson S, MacLean P (2017) Metformin accumulation correlates with organic cation transporter 2 protein expression and predicts mammary tumor regression in vivo. Cancer Prev Res (Phila)","DOI":"10.1158\/1940-6207.CAPR-16-0211-T"},{"issue":"2","key":"302_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00708323","volume":"409","author":"W Remmele","year":"1986","unstructured":"Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B, Scheidt E (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 409(2):127\u2013147","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"302_CR30","doi-asserted-by":"crossref","unstructured":"Feng J, Li L, Zhang N, Liu J, Zhang L, Gao H, Wang G, Li Y, Zhang Y, Li X, Liu D, Lu J, Huang B (2016) Androgen and Ar Contribute to Breast Cancer Development and Metastasis: An Insight of Mechanisms. Oncogene","DOI":"10.1038\/onc.2016.432"},{"issue":"6","key":"302_CR31","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1194\/jlr.M044487","volume":"55","author":"MC Rudolph","year":"2014","unstructured":"Rudolph MC, Wellberg EA, Lewis AS, Terrell KL, Merz AL, Maluf NK, Serkova NJ, Anderson SM (2014) Thyroid hormone responsive protein Spot14 enhances catalysis of fatty acid synthase in lactating mammary epithelium. J Lipid Res 55(6):1052\u20131065","journal-title":"J Lipid Res"},{"issue":"6","key":"302_CR32","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13058-014-0481-z","volume":"16","author":"EA Wellberg","year":"2014","unstructured":"Wellberg EA, Rudolph MC, Lewis AS, Padilla-Just N, Jedlicka P, Anderson SM (2014) Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis. Breast Cancer Res 16(6):481","journal-title":"Breast Cancer Res"},{"key":"302_CR33","first-page":"13","volume":"8","author":"T Casneuf","year":"2016","unstructured":"Casneuf T, Axel AE, King P, Alvarez JD, Werbeck JL, Verhulst T, Verstraeten K, Hall BM, Sasser AK (2016) Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-alpha-positive breast cancer. Breast Cancer (Dove Med Press) 8:13\u201327","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"7","key":"302_CR34","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.ijo.0801254","volume":"24","author":"PG McTernan","year":"2000","unstructured":"McTernan PG, Anwar A, Eggo MC, Barnett AH, Stewart PM, Kumar S (2000) Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. Int J Obes Relat Metab Disord 24(7):875\u2013881","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1\u20135","key":"302_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jsbmb.2007.05.007","volume":"106","author":"Y Miki","year":"2007","unstructured":"Miki Y, Suzuki T, Sasano H (2007) Controversies of aromatase localization in human breast cancer\u2014stromal versus parenchymal cells. J Steroid Biochem Mol Biol 106(1\u20135):97\u2013101","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"13","key":"302_CR36","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","volume":"367","author":"HI Scher","year":"2012","unstructured":"Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, de Wit R, Mulders P, Chi KN, Shore ND, Armstrong AJ, Flaig TW, Flechon A, Mainwaring P, Fleming M, Hainsworth JD, Hirmand M, Selby B, Seely L, de Bono JS, Investigators A (2012) Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367(13):1187\u20131197","journal-title":"N Engl J Med"},{"issue":"5","key":"302_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2164\/jandrol.108.005454","volume":"29","author":"S Basaria","year":"2008","unstructured":"Basaria S (2008) Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl 29(5):534\u2013539","journal-title":"J Androl"},{"issue":"24","key":"302_CR38","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","volume":"24","author":"M Braga-Basaria","year":"2006","unstructured":"Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J, Basaria S (2006) Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 24(24):3979\u20133983","journal-title":"J Clin Oncol"},{"issue":"9\u201310","key":"302_CR39","doi-asserted-by":"publisher","first-page":"E300","DOI":"10.5489\/cuaj.3655","volume":"10","author":"MM Rezaei","year":"2016","unstructured":"Rezaei MM, Rezaei MM, Ghoreifi A, Kerigh BF (2016) Metabolic syndrome in patients with prostate cancer undergoing intermittent androgen-deprivation therapy. Can Urol Assoc J 10(9\u201310):E300\u2013E305","journal-title":"Can Urol Assoc J"},{"issue":"10","key":"302_CR40","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1002\/cncr.26559","volume":"118","author":"LL Lipscombe","year":"2012","unstructured":"Lipscombe LL, Fischer HD, Yun L, Gruneir A, Austin P, Paszat L, Anderson GM, Rochon PA (2012) Association between tamoxifen treatment and diabetes: a population-based study. Cancer 118(10):2615\u20132622","journal-title":"Cancer"},{"issue":"35","key":"302_CR41","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/JCO.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA (2016) Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol 34(35):4270\u20134276","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"302_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mce.2011.05.033","volume":"360","author":"Z Culig","year":"2012","unstructured":"Culig Z, Puhr M (2012) Interleukin-6: a multifunctional targetable cytokine in human prostate cancer. Mol Cell Endocrinol 360(1\u20132):52\u201358","journal-title":"Mol Cell Endocrinol"},{"issue":"20","key":"302_CR43","first-page":"4640","volume":"58","author":"A Hobisch","year":"1998","unstructured":"Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H, Culig Z (1998) Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58(20):4640\u20134645","journal-title":"Cancer Res"},{"issue":"3","key":"302_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-010-0761-y","volume":"124","author":"I Castellano","year":"2010","unstructured":"Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A (2010) Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat 124(3):607\u2013617","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"302_CR45","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1158\/1078-0432.CCR-10-2021","volume":"17","author":"R Hu","year":"2011","unstructured":"Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM (2011) Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res 17(7):1867\u20131874","journal-title":"Clin Cancer Res"},{"issue":"4","key":"302_CR46","doi-asserted-by":"publisher","first-page":"T161","DOI":"10.1530\/ERC-14-0243","volume":"21","author":"KM McNamara","year":"2014","unstructured":"McNamara KM, Moore NL, Hickey TE, Sasano H, Tilley WD (2014) Complexities of androgen receptor signalling in breast cancer. Endocr Relat Cancer 21(4):T161\u2013T181","journal-title":"Endocr Relat Cancer"},{"issue":"15","key":"302_CR47","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1038\/emboj.2011.216","volume":"30","author":"JL Robinson","year":"2011","unstructured":"Robinson JL, Macarthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG, Carroll JS (2011) Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by Foxa1. EMBO J 30(15):3019\u20133027","journal-title":"EMBO J"},{"issue":"11","key":"302_CR48","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1002\/ijc.21730","volume":"118","author":"S Rinaldi","year":"2006","unstructured":"Rinaldi S, Key TJ, Peeters PH, Lahmann PH, Lukanova A, Dossus L, Biessy C, Vineis P, Sacerdote C, Berrino F, Panico S, Tumino R, Palli D, Nagel G, Linseisen J, Boeing H, Roddam A, Bingham S, Khaw KT, Chloptios J, Trichopoulou A, Trichopoulos D, Tehard B, Clavel-Chapelon F, Gonzalez CA, Larranaga N, Barricarte A, Quiros JR, Chirlaque MD, Martinez C, Monninkhof E, Grobbee DE, Bueno-de-Mesquita HB, Ferrari P, Slimani N, Riboli E, Kaaks R (2006) Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the epic cohort. International journal of cancer Journal international du cancer 118(11):2832\u20132839","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"16","key":"302_CR49","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/jnci\/djg022","volume":"95","author":"TJ Key","year":"2003","unstructured":"Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE Jr, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C, Endogenous Hormones Breast Cancer Collaborative G (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218\u20131226","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"302_CR50","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1158\/1078-0432.CCR-09-0640","volume":"15","author":"JY Chun","year":"2009","unstructured":"Chun JY, Nadiminty N, Dutt S, Lou W, Yang JC, Kung HJ, Evans CP, Gao AC (2009) Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res 15(15):4815\u20134822","journal-title":"Clin Cancer Res"},{"issue":"3","key":"302_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2012-1055","volume":"34","author":"F Mauvais-Jarvis","year":"2013","unstructured":"Mauvais-Jarvis F, Clegg DJ, Hevener AL (2013) The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34(3):309\u2013338","journal-title":"Endocr Rev"},{"issue":"4","key":"302_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/oby.21033","volume":"23","author":"G Navarro","year":"2015","unstructured":"Navarro G, Allard C, Xu W, Mauvais-Jarvis F (2015) The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring) 23(4):713\u2013719","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"302_CR53","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S1470-2045(14)70129-9","volume":"15","author":"B Tombal","year":"2014","unstructured":"Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, Heidenreich A, Iversen P, Braeckman J, Heracek J, Baskin-Bey E, Ouatas T, Perabo F, Phung D, Hirmand M, Smith MR (2014) Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study. The lancet oncology 15(6):592\u2013600","journal-title":"The lancet oncology"},{"issue":"3","key":"302_CR54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10549-008-9923-6","volume":"112","author":"DM Harvell","year":"2008","unstructured":"Harvell DM, Richer JK, Singh M, Spoelstra N, Finlayson C, Borges VF, Elias AD, Horwitz KB (2008) Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor. Breast Cancer Res Treat 112(3):489\u2013501","journal-title":"Breast Cancer Res Treat"},{"key":"302_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jsbmb.2014.09.012","volume":"145","author":"F Labrie","year":"2015","unstructured":"Labrie F (2015) Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men. J Steroid Biochem Mol Biol 145:131\u2013132","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"302_CR56","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1158\/0008-5472.CAN-13-2779","volume":"74","author":"MJ Sikora","year":"2014","unstructured":"Sikora MJ, Cooper KL, Bahreini A, Luthra S, Wang G, Chandran UR, Davidson NE, Dabbs DJ, Welm AL, Oesterreich S (2014) Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response. Cancer Res 74(5):1463\u20131474","journal-title":"Cancer Res"},{"issue":"1","key":"302_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/13697137.2014.929105","volume":"18","author":"I Kyvernitakis","year":"2015","unstructured":"Kyvernitakis I, Albert US, Kalder M, Winarno AS, Hars O, Hadji P (2015) Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer. Climacteric 18(1):63\u201368","journal-title":"Climacteric"},{"issue":"2","key":"302_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1677\/ERC-09-0257","volume":"17","author":"K Takagi","year":"2010","unstructured":"Takagi K, Miki Y, Nagasaki S, Hirakawa H, Onodera Y, Akahira J, Ishida T, Watanabe M, Kimijima I, Hayashi S, Sasano H, Suzuki T (2010) Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment. Endocr Relat Cancer 17(2):415\u2013430","journal-title":"Endocr Relat Cancer"},{"issue":"19","key":"302_CR59","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1200\/JCO.2008.18.6213","volume":"27","author":"E Rossi","year":"2009","unstructured":"Rossi E, Morabito A, Di Rella F, Esposito G, Gravina A, Labonia V, Landi G, Nuzzo F, Pacilio C, De Maio E, Di Maio M, Piccirillo MC, De Feo G, D'Aiuto G, Botti G, Chiodini P, Gallo C, Perrone F, de Matteis A (2009) Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the Hoboe trial. J Clin Oncol 27(19):3192\u20133197","journal-title":"J Clin Oncol"},{"issue":"7","key":"302_CR60","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/annonc\/mdf083","volume":"13","author":"E Bajetta","year":"2002","unstructured":"Bajetta E, Martinetti A, Zilembo N, Pozzi P, La Torre I, Ferrari L, Seregni E, Longarini R, Salvucci G, Bombardieri E (2002) Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism. Annals of oncology: official journal of the European Society for Medical Oncology \/nnnnnnESMO 13(7):1059\u20131066","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology \/nnnnnnESMO"},{"issue":"4","key":"302_CR61","first-page":"1367","volume":"31","author":"SJ Stanway","year":"2011","unstructured":"Stanway SJ, Palmieri C, Stanczyk FZ, Folkerd EJ, Dowsett M, Ward R, Coombes RC, Reed MJ, Purohit A (2011) Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer. Anticancer Res 31(4):1367\u20131372","journal-title":"Anticancer Res"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-017-0302-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-017-0302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-017-0302-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T17:12:53Z","timestamp":1609261973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-017-0302-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,24]]},"references-count":61,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1007\/s12672-017-0302-9","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,24]]},"assertion":[{"value":"27 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported by the Cancer League of Colorado (EAW), the University of Colorado Nutrition and Obesity Research Center Pilot Awards P30-DK048520 (EAW, EDG, PSM), NIH\/NCI CA164166 (PSM, PS) and CA169430 (EDG), and the Komen Foundation KG081323 (SMA). EAW and EDG were supported by seed grants from the University of Colorado\u2019s Center for Women\u2019s Health Research. We also appreciate the generous support from both the Colorado Obesity Research Institute, and the Energy Balance and Metabolic Core Laboratories within the Colorado Nutrition Obesity Research Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding Sources"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}